ARGX argenx NV ADR

USD 614.76 +14.25 ( +2.37%)
Icon

argenx NV ADR (ARGX) Financial Statements

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 614.76

+14.25 (+2.37%)

USD 35.43B

0.22M

USD 737.13(+19.90%)

USD 516.67 (-15.96%)

Icon

ARGX

argenx NV ADR (USD)
COMMON STOCK | NSD
USD 614.76
+14.25 ( +2.37%)

argenx NV ADR (ARGX) Annual Income Statement (USD)

ARGX Quarterly Financials (USD)

Frequently Asked Questions About argenx NV ADR (ARGX) Stock

argenx NV ADR's (ARGX) last reported annual revenue was USD 2.19 Billion.

argenx NV ADR's (ARGX) annual revenue growth rate based on the revenue reported in the past 5 years is : 94.61%

argenx NV ADR's(ARGX) is profitable as of its last reported annual financials.

The net profit margin for argenx NV ADR's(ARGX) from its laster reported year is 38.03%

The return on equity (ROE) for argenx NV ADR's(ARGX) from its last reported annual financials is : 17.36%

The return on assets (ROA) for argenx NV ADR's(ARGX) from its last reported annual financials is : -0.21%

The return on invested capital (ROIC) for argenx NV ADR's(ARGX) from its last reported annual financials is : 15.41%

The Debt to Equity ratio for argenx NV ADR's(ARGX) from its last reported annual financials is : 0.00%

The dividend yield for argenx NV ADR's(ARGX) from its laster reported year is 0.00%

argenx NV ADR's(ARGX) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...